Fundraising Fox
/Companies
Sign in

Female Health

NASDAQ: VERU

Chicago, US · Wisconsin corporation

Find your way into Female Health

Sign up to see every warm intro you have to Female Health

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Female Health team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Veru is a biopharmaceutical company developing and commercializing treatments for cardiometabolic and oncology conditions. Its lead programs include enobosarm, an oral selective androgen receptor modulator aimed at preventing muscle loss in patients on GLP-1 weight loss therapy, and sabizabulin, an oral microtubule targeting agent for KRAS-driven metastatic pancreatic cancer resistant to existing therapy.

BiotechHealthtech

Founders & leadership

MS
Mitchell SteinerChief Executive Officer
DH
Daniel HainesExecutive
MS
Mitchell S. Steiner, M.D., F.A.C.S.President, Chief Executive Officer and Chairman of the Board
HF
Harry Fisch, M.D., F.A.C.S.Chief Corporate Officer, Vice Chairman of the Board and Director
OP
O.B. ParrishNamed on SEC filing

Board

HF
Harry FischBoard director
GM
Georges MakhoulBoard director
EP
Elgar PeerschkeBoard director
DR
David R. BethuneBoard director
ME
Mario EisenbergerBoard director
LL
Lucy LuBoard director
MM
Mary Margaret FrankBoard director

Reported raises · per SEC filings

Form D private placements

$22.7M disclosed across 1 round · 2016

▶$22.7MraisedNov 2016 · 23 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Harry FischDirector
  • Georges MakhoulDirector
  • Mitchell S. SteinerExecutive Officer, Director
  • Elgar PeerschkeDirector
  • David R. BethuneDirector
  • Mario EisenbergerDirector
  • O.B. ParrishDirector
  • Daniel HainesExecutive Officer
  • Lucy LuDirector
  • Mary Margaret FrankDirector
Offering amount
$22.7M
Amount sold
$22.7M
Finders' fees
$973.9K
Placement agents
Financial West Group
First sale
Oct 2016
Incorporated
Corporation, Wisconsin
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Female Health do?
Veru is a biopharmaceutical company developing and commercializing treatments for cardiometabolic and oncology conditions. Its lead programs include enobosarm, an oral selective androgen receptor modulator aimed at preventing muscle loss in patients on GLP-1 weight loss therapy, and sabizabulin, an oral microtubule targeting agent for KRAS-driven metastatic pancreatic cancer resistant to existing therapy.
Who founded Female Health?
Female Health was founded by Mitchell Steiner.
How much funding has Female Health raised?
Female Health has disclosed $22.7M raised across 1 round.
Where is Female Health headquartered?
Female Health is headquartered in Chicago, US.